Michael Rowe

Consultant Clinical Oncologist in Cornwall, UK. Co-host @simplyoncology Podcast. Chair- NOTCH Advisory Board @onctrainees. GI and Urological malignancies

[John McGrane @mcgranjo777]

🚨Simply Oncology Podcast on the ADePT trial in GBM- Dual Payload Gene Therapy🚨
1st human enrolled!
👏The science & pre human work are incredible.
🎙️ Dr Faye Robertson Edinburgh Cancer Centre talks us through the Trojan Horse that is TGX-007.
Enjoy!
@BrainTumourOrg @OncoAlert

[OncoAlert @OncoAlert]

RASolute 302 : Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

https://t.co/o2BtMfTRph

In this phase 3 trial of 500 patients with previously treated metastatic pancreatic ductal adenocarcinoma, the oral RAS(ON) inhibitor daraxonrasib significantly improved outcomes versus investigator’s-choice chemotherapy🧪 . Median overall survival doubled (13.2 vs. 6.6–6.7 months), while progression-free survival also improved 📈 substantially (7.2–7.3 vs. 3.5–3.6 months). Benefits were consistent across populations, including RAS G12-mutant disease. Daraxonrasib demonstrated a manageable safety profile, with fewer treatment discontinuations than chemotherapy. #PancreaticCancer

@EileenMOReilly
@WainbergZev
@DrHendifar
@MiteshBorad
@FilippoPietran4
@DrShubhamPant
@ChiaraCrem1
@DrGManji
@md_oberstein
@GarridoLagunaMD

@pashtoonkasi @CathyEngMD @marklewismd @manjuggm @ARosen380 @KoheiShitara @GillSharlene @BenWestphalen @graokane

[John McGrane @mcgranjo777]

🚨New Simply Oncology Podcast out today on RT in Pancreatic Cancer🚨

We talk to the superb Dr Ganesh Radhakhrisna from @CICEManchester about SABR / RT and its increasing role in #PancreaticCancer

🎯Exciting times for Panc Ca

@OncoAlert @PancreaticCanUK @RCRadiologists

[Simply Oncology @simplyoncology]

Check out our next episode focus on radiotherapy in pancreatic cancer https://t.co/U097yih2T6

[John McGrane @mcgranjo777]

🎙️A real treat episode of Simply Oncology Podcast in front of an audience with these amazing people
🎙️Lifestyle 🥙, Patient Voice🗣️ & Exercise 🏃‍♂️in #ProstateCancer with the amazing Tony Collier, @lucygoss & @AlisonBirtle ⭐️

Coming soon 🎯

@PCR_News @OncoAlert @ethansgrumps

[Piet Ost @piet_ost]

🔬 PEACE 2 phase III: Adding pelvic RT to prostate RT + 3y ADT in very high-risk localized prostate cancer did NOT improve bPFS, MFS, CSS or OS. Borderline cPFS signal (HR 0.81, p=0.09). No added AEs. @PBlanchard_MD #ESTRO2026. @VedangMurthy what now?

[Simply Oncology @simplyoncology]

we talk to Annie Anderson on advanced kidney cancer and its treatment.
Annie was diagnosed with stage IV Kidney Cancer in 2022.
She describes how continuing the things that give her joy have allowed her retain her sense of self along the way #inspired

[Katy Beckermann @katy_beckermann]

After radical cystectomy, pelvic recurrence is devastating and we've had almost no tools to predict who's at risk before it happens.

This Mayo/Milan 5-factor model changes that.
➡️ Derived from 1,200 cases. Externally validated.
➡️ Gives us a framework to identify adjuvant RT candidates upfront not reactively (T stage, node+, margin+, <20 LNs removed)

We ask patients to accept big surgery and maybe this score can tell us who needs more. Hope the numbers at risk continue to decrease in the era of EV+P. 💡
#BladderCancer #GUOncology

[John McGrane @mcgranjo777]

🎉100 episodes of Simply Oncology Podcast🎉

🎙️27000 + downloads
🌍119 countries all across the globe.
🏘️1600 towns and cities
⭐️59 Amazing guests

Thank you to all our guests and listeners😍

Also a big thank you to people and teams supporting us along the way!!

[John McGrane @mcgranjo777]

🚨Simply Oncology Podcast on Adjuvant Therapy in #KidneyCancer out today🚨

🎉Joins us as we celebrate 100 episodes in style🎉

🎙️We talk to @will_oncology Ince @nav_vasudev about HUGELY EXCITING the adjuvant space in RCC.

@OncoAlert @KidneyCancer
@IKCCorg @UrowebESU

[John McGrane @mcgranjo777]

A huge thank you to all our listeners and guests🙌🏽
We are delighted to have some amazing new episodes on the horizon🎯
#renalcancer
#pancreaticcancer
#Ovariancancer
#Bladdercancer
#Breastcancer

[Simply Oncology @simplyoncology]

The Simply Oncology podcast has over 25,000 downloads! Thank you to all our listeners!! https://t.co/DcAFSupbXG

[Simply Oncology @simplyoncology]

Check out our next episode (nearly 100!!) with Dr Toby Talbot on early melanoma treatments @focusonmelanoma
https://t.co/KpDHLBMbOg

[Jose Tapia @TapiaJC1]

Great news. Ph3 RASolute-302 RCT #daraxonrasib in pts with prev treated metastatic #pancreatic #PDAC demonstrated a mOS of 13.2 vs 6.7 mo for chemo (HR 0.40 (p &lt; 0.0001). RCT in the 1L coming soon (2026).

https://t.co/4rD0wjXMcK

[Simply Oncology @simplyoncology]

Great next Fundamentals for anyone getting to grips with the world of #cancer. @BONUSOncSoc @macmillancancer @RCRadiologists @CharityAMMF @BreastCancerNow @ProstateUK @ACTION4KC @BladderCancerUK @bowelcanceruk @SU2C

[John McGrane @mcgranjo777]

🚨New Simply Oncology podcast on the A to Z of Oncology🚨

🎙️Are you a patient or care who is newly diagnosed with cancer.

🎙️Are you new to working around cancer care.

🎙️Are you in training and want to learn more.
Feel free to send in your own A-Z 👍
@OncoAlert @BAUNnurses

[Yüksel Ürün @DrYukselUrun]

Can ¹⁷⁷Lu-PSMA-617 fill that gap in oligometastatic HSPC?
🔹mPFS 25 vs 5 months. 52% PSA90.
🔹PEACE-1, ARASENS intensified ADT, BULLSEYE tried to defer it. Different question. Different patient.
🔹Is there room for theranostics before hormones? Maybe yes, in PSMA-avid, oligometastatic patients not ready for ADT. 🔹Phase 3 will tell. Real comparator might be MDT/SBRT. @TheLancetOncol @APCCC_Lugano @OncoAlert

[Simply Oncology @simplyoncology]

Catch our next episode with Prof Aggarwal on #AI

[John McGrane @mcgranjo777]

🚨 New Simply oncology Podcast on Artificial intelligence in Radiotherapy 🚨

AI is the new answer to all things 🧐

🏹 We discuss the international ARCHERY trial using an AI radiotherapy planning tool to streamline RT planning with Prof Ajay Aggarwal🎯
@OncoAlert @ICR_London

[John McGrane @mcgranjo777]

🎙️Simply Oncology Podcast on PSMA Lutetium in #ProstateCancer out today with the superb Dr Amy Eccles
🎙️ Prostate Cancer Awareness Month we discuss➡️ future of PSMA lutetium &amp; other molecular radiotherapy targets in PCa

🎙️Part 2 of 2
@OncJournal @OncoAlert @BNMSnews @UrowebESU